Life Sciences Industry Report – Part 4

Digital
Life Sciences Industry Report 2025 pt4 cover

One of the most remarkable shifts in modern healthcare is how seamlessly digital platforms are becoming part of the drug development journey.

In Part 4 of our Life Sciences Industry Report, we turn our attention to advanced data analytics, wearable health devices, and AI-driven models – all working together to shorten the path from the lab bench to the patient’s bedside.

The agility of software development stands in stark contrast to traditional pharmaceutical development cycles. And recent regulatory frameworks, particularly the FDA’s Prescription Drug Use-Related Software guidance, signal a maturing ecosystem that recognises software’s unique position in healthcare delivery.

Challenges remain, of course: there exist yet questions around data privacy, hardware suitability, and making sure that digital health solutions are accessible to all. Balancing the rapid pace of innovation with patient safety and ethical standards isn’t easy, but it’s essential.

In Part 4 of pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the digital health trends that propelled the pharmaceutical industry along in 2024. Download Part 4 today.